Articles From: TMX Group Consolidated Trading Statistics - September 2014 to Toledo Edison and Owens Community College to Offer Training Program for Future Utility Workers


2014/10/2
TMX Group Consolidated Trading Statistics - September 2014 Canada NewsWire TORONTO , Oct.
Sign-up for TMX Group Consolidated Trading Statistics - September 2014 investment picks
2014/12/4
TMX Group Equity Financing Statistics - November 2014 Canada NewsWire Toronto Stock Exchange, TSX Venture Exchange TORONTO , Dec.
Sign-up for TMX Group Equity Financing Statistics - November 2014 investment picks
2014/12/2
TMX Group Holiday Operating Schedule Canada NewsWire TORONTO , Dec.
Sign-up for TMX Group Holiday Operating Schedule investment picks
2014/11/14
TMX Group launches TSX Private Markets Canada NewsWire TORONTO , Nov.
Sign-up for TMX Group launches TSX Private Markets investment picks
2014/10/7
TMX Group Limited announces release date for Q3 2014 financial results and analyst conference call Canada NewsWire TORONTO , Oct.
Sign-up for TMX Group Limited announces release date for Q3 2014 financial results and analyst conference call investment picks
TORONTO , Sept.
Sign-up for TMX Group Limited Appoints Lou Eccleston as Chief Executive Officer investment picks
2014/11/6
TORONTO , Nov.
Sign-up for TMX Group Limited declares dividend of $0.40 per common share investment picks
2014/11/6
TMX Group Limited declares dividend of $0.40 per common share Canada NewsWire TORONTO , Nov.
Sign-up for TMX Group Limited declares dividend of $0.40 per common share investment picks
2014/10/23
TMX Group to Streamline its Equities Trading Offering Canada NewsWire TORONTO , Oct.
Sign-up for TMX Group to Streamline its Equities Trading Offering investment picks
TMX Group's Brenda Hoffman Named ITAC CanadianCIO of the Year Canada NewsWire TORONTO , Nov.
Sign-up for TMX Group's Brenda Hoffman Named ITAC CanadianCIO of the Year investment picks
2014/9/23
TMX Group launches award-winning trading engine on Canada's public venture capital marketplace TORONTO , Sept.
Sign-up for TMX Quantum XA launched on TSX Venture Exchange investment picks
2014/11/4
The proliferation of streaming video alternatives, while still posing a long-term competitive challenge for traditional Pay TV providers, may also be producing beneficial results across the service category, as indicated by a recent consumer survey from global research consultancy TNS.
Sign-up for TNS Survey Finds Emergence of Streaming Video Brings Pressures and Profits to Traditional Pay TV Providers investment picks
2014/9/24
By Sara Sjolin, MarketWatch LONDON (MarketWatch) -- Here are some of the companies whose shares are making notable moves in Wednesday's European trading session.
Sign-up for TNT Express slumps; Rio Tinto climbs: Europe's big stock movers investment picks
Builds Expert Independent Board As Company Advances Towards Late-Stage Brain Cancer Trials SAN DIEGO , Nov.
Sign-up for Tocagen Appoints Faheem Hasnain as Chairman of the Board of Directors investment picks
2014/10/2
The lively, funny and entertaining co-stars of NBC TODAY’s fourth hour are putting down their wine glasses and joining WWE ® as guest stars on Monday Night Raw ® on October 6 at 8PM ET/7PM CT on USA Network.
Sign-up for TODAY Invades WWE® Monday Night Raw® on October 6 with Hoda Kotb and Kathie Lee Gifford investment picks
2014/11/13
Autobytel Dealer Awards Program Honors Exceptional Dealers for Outstanding Internet Lead Management and Customer Service Standards.
Sign-up for Todd Hilleboe, General Manager of Larry H. Miller Liberty Toyota, Named the Autobytel September 2014 Dealer of the Month investment picks
2014/11/12
CRANFORD, N.J. , Nov.
Sign-up for Tofutti Announces Third Quarter and Nine Month Results investment picks
Tokai Pharmaceuticals, Inc. (NASDAQ: TKAI), a clinical-stage biopharmaceutical company focused on developing novel therapies for prostate cancer and other hormonally-driven diseases, today announced the closing of its initial public offering of 6,480,000 shares of its common stock at an initial public offering price of $15.00 per share, resulting in gross proceeds of $97.2 million, before underwriting discounts and commissions.
Sign-up for Tokai Pharmaceuticals Announces Closing of Initial Public Offering investment picks
Tokai Pharmaceuticals, Inc. (NASDAQ: TKAI), a clinical-stage biopharmaceutical company focused on developing novel therapies for prostate cancer and other hormonally driven diseases, today announced that updated, interim results from the company’s ongoing Phase 2 clinical trial, ARMOR2, of its lead drug candidate, galeterone, in patients with castration resistant prostate cancer (CRPC) will be presented at the 26 th EORTC-NCI-AACR Symposium on Molecular Targets in Cancer Therapeutics being held November 18-21 in Barcelona, Spain.
Sign-up for Tokai Pharmaceuticals Announces Interim Phase 2 Data on Galeterone in Patients with Advanced Prostate Cancer to be Presented at the EORTC-NCI-AACR Symposium investment picks
2014/9/17
Tokai Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on developing novel therapies for prostate cancer and other hormonally-driven diseases, today announced the pricing of its initial public offering of 6,480,000 shares of common stock at a public offering price of $15.00 per share, before underwriting discounts and commissions.
Sign-up for Tokai Pharmaceuticals Announces Pricing of Initial Public Offering investment picks
Tokai Pharmaceuticals, Inc. (NASDAQ: TKAI), a biopharmaceutical company focused on developing novel therapies for prostate cancer and other hormonally-driven diseases, today announced that updated, interim results from the company’s ongoing Phase 2 clinical trial, ARMOR2, of its lead drug candidate, galeterone, in patients with castration resistant prostate cancer (CRPC) will be presented at the European Society for Medical Oncology (ESMO) 2014 Congress, September 26-30, in Madrid, Spain.
Sign-up for Tokai Pharmaceuticals Announces Updated Phase 2 Data on Galeterone in Patients with Advanced Prostate Cancer to be Presented at the ESMO 2014 Congress investment picks
Tokai Pharmaceuticals, Inc. (NASDAQ:TKAI) today announced updated interim results from its ongoing ARMOR2 Phase 2 clinical trial of galeterone in castration-resistant prostate cancer (CRPC) patients.
Sign-up for Tokai Pharmaceuticals Presents Updated Interim Galeterone ARMOR2 Data Showing Activity in Patients with Castration-Resistant Prostate Cancer (CRPC) Including Those Showing a Variant Form of Prostate Cancer Resistant to Hormone Therapy investment picks
Tokai Pharmaceuticals, Inc. (NASDAQ: TKAI) today announced updated interim results from its ongoing Phase 2 clinical trial, ARMOR2, evaluating galeterone as a treatment for patients with castration-resistant prostate cancer (CRPC). These data demonstrated clinically meaningful reductions in prostate-specific androgen (PSA) levels, a marker of prostate cancer growth.
Sign-up for Tokai Pharmaceuticals Presents Updated Phase 2 Data on Galeterone in Patients with Advanced Prostate Cancer at ESMO 2014 investment picks
Tokai Pharmaceuticals, Inc. (NASDAQ: TKAI), a clinical-stage biopharmaceutical company focused on developing novel therapies for prostate cancer and other hormonally driven diseases, today reported company highlights and financial results for the quarter ended September 30, 2014.
Sign-up for Tokai Pharmaceuticals Reports Third Quarter 2014 Financial Results investment picks
Tokai Pharmaceuticals, Inc. (NASDAQ:TKAI), a clinical-stage biopharmaceutical company focused on developing novel therapies for prostate cancer and other hormonally driven diseases, today announced that Jodie Morrison, president and chief executive officer, will provide a company overview at two November investment conferences: Live webcasts of these presentations can be accessed under the “Calendar of Events” page within the Investors & Media section of the company’s website at www.tokaipharma.com .
Sign-up for Tokai Pharmaceuticals to Present at Upcoming Healthcare Investor Conferences investment picks
2014/11/6
By Chao Deng and Bradford Frischkorn Stocks in Tokyo fell Thursday, snapping a five-day winning streak, as a volatile dollar had investors taking profits in exporters and other yen-sensitive shares.
Sign-up for Tokyo stocks fall as dollar moves prompt profit-taking investment picks
2014/10/17
Power Systems Institute Will Train Students to Work on Power Lines and in Substations TOLEDO, Ohio , Oct.
Sign-up for Toledo Edison and Owens Community College to Offer Training Program for Future Utility Workers investment picks
Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: TMX Group Consolidated Trading Statistics - September 2014 to Toledo Edison and Owens Community College to Offer Training Program for Future Utility Workers
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent